402.43
Overview
News
Price History
Option Chain
Financials
Why ELV Down?
Discussions
Forecast
Stock Split
Dividend History
Elevance Health Inc stock is traded at $402.43, with a volume of 1.11M.
It is down -1.68% in the last 24 hours and up +0.47% over the past month.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
See More
Previous Close:
$409.31
Open:
$412.07
24h Volume:
1.11M
Relative Volume:
0.82
Market Cap:
$87.27B
Revenue:
$201.11B
Net Income/Loss:
$4.95B
P/E Ratio:
17.89
EPS:
22.4991
Net Cash Flow:
$6.29B
1W Performance:
-3.62%
1M Performance:
+0.47%
6M Performance:
+38.06%
1Y Performance:
+26.59%
Elevance Health Inc Stock (ELV) Company Profile
Name
Elevance Health Inc
Sector
Industry
Phone
(800) 331-1476
Address
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ELV
Elevance Health Inc
|
402.43 | 90.81B | 201.11B | 4.95B | 6.29B | 22.50 |
|
UNH
Unitedhealth Group Inc
|
372.95 | 340.27B | 450.13B | 14.91B | 23.62B | 15.55 |
|
CVS
Cvs Health Corp
|
87.10 | 121.07B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
CI
Cigna Group
|
273.74 | 74.19B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
372.00 | 49.21B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-08-26 | Initiated | Evercore ISI | In-line |
| Feb-03-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-08-26 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-19-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-14-25 | Initiated | Goldman | Neutral |
| Jul-21-25 | Downgrade | Argus | Buy → Hold |
| Jul-18-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-17-25 | Upgrade | Argus | Hold → Buy |
| Jan-22-25 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-18-24 | Downgrade | Argus | Buy → Hold |
| Jul-18-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-24-24 | Initiated | Morgan Stanley | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-27-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-28-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-22-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
View All
Elevance Health Inc Stock (ELV) Latest News
Why Does Elevance Health (NYSE:ELV) Matter in S&P 500? - Kalkine Media
Elevance leads UBS health benefits survey as employers brace for higher costs (ELV:NYSE) - Seeking Alpha
Can Centene's Medicare Advantage Strategy Unlock Better Margins? - Zacks Investment Research
BofA Securities Adjusts Elevance Health Price Target to $480 From $460 - Moomoo
Elevance Health stock gains after reaffirmed 2026 earnings guidance - ad-hoc-news.de
Elevance Health Reaffirms 2026 Earnings and Cost Guidance - The Globe and Mail
ELV (Elevance Health) 5-Year EBITDA Growth Rate : 5.30% (As of Jun. 2026) - GuruFocus
Elevance Health Inc (ELV) Shares Surge 5.0% -- What GF Score of 90 Tells Investors - GuruFocus
ELV Stock Steadies As Oppenheimer Meeting Nears - StocksToTrade
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Should You Buy Elevance Health Stock For The Margin It Lost? - Trefis
Elevance Health reaffirms FY26 EPS guidance, shares rise 5% - scanx.trade
Elevance Health stock gains after 2026 earnings guidance is reaffirmed - ad-hoc-news.de
Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation - Benzinga
Why is Elevance Health stock surging today? By Investing.com - Investing.com Nigeria
Elevance Health Inc Stock (ELV) Moved Up by 5.50% on Sep 10: Drivers Behind the Movement - TradingKey
Elevance Health reaffirms 2026 earnings and benefit expense guidance By Investing.com - Investing.com South Africa
Elevance Health reaffirms 2026 earnings and benefit expense guidance - Investing.com
Elevance Health Gains as Investors Revisit Medicare Advantage Tailwinds - Quiver Quantitative
Elevance Health (ELV) Reaffirms 2026 Earnings Guidance of at Lea - GuruFocus
Elevance holds loss ratio guidance above 90% as fall renewals near - Insurance Business
Elevance Health at Wells Fargo conference: growth plan stays on track - Investing.com UK
Elevance Health Inc's Dividend Analysis - GuruFocus
Form 8K Elevance Health Inc For: 10 September By Investing.com - Investing.com Canada
Elevance Health (NYSE: ELV) sticks with its 2026 profit target - Stock Titan
Elevance Health Inc. stock outperforms competitors despite losses on the day - MarketWatch
Elevance Health stock falls amid sector worries over rising medical costs - ad-hoc-news.de
Bernstein Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $488 - Moomoo
Elevance Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Elevance Health EVP and Chief Legal Officer Wessling Erin M Forfeits 349 Shares, Retains 7,230 Shares - Kalkine Media
2 Reasons to Watch ELV and 1 to Stay Cautious - Yahoo Finance
Elevance Health stock falls on softer dividend yield and valuation concerns - AD HOC NEWS
Gail Boudreaux | Elevance Health CEO & Former Dartmouth Basketball Star - Britannica
Elevance Health stock holds after strong quarterly beat - AD HOC NEWS
Elevance Health, Inc. (ELV) Stock Analysis: Evaluating A 10% Upside Potential - DirectorsTalk Interviews
Elevance Health stock holds steady as Medicare Advantage shift and dividend set the tone - AD HOC NEWS
Health insurer Anthem targeted in lawsuit over air ambulance claims - The Republic News
Elevance Health (ELV) Q2 2026 Earnings Call Transcript - Fortune
Elevance Health Inc. stock underperforms Friday when compared to competitors - MarketWatch
Elevance Health (NYSE: ELV) withholds 349 shares to cover EVP tax liability - Stock Titan
EVP at Elevance Health (NYSE: ELV) now holds 6,530 shares after tax withholding - Stock Titan
Elevance Health Settles Ex-Worker's Late Pay Class Claims - Law360
UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy? - TradingView
Elevance Health (NYSE:ELV) Valuation Gap Persists After Rally - Kalkine Media
Is UnitedHealth Finally Turning the Corner After a Tough 2025? - TradingView
How Is Elevance Health’s Stock Performance Compared to Other Health Providers? - Yahoo Finance
Elevance Health, Inc. $ELV Shares Bought by Northwestern Mutual Wealth Management Co. - MarketBeat
Elevance Health (ELV) Soars as Investors Gain Confidence in Profitability - Yahoo Finance
Elevance Health (ELV): Bridging the Gap between Care and Coverage - finance.yahoo.com
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Shenzhen Edge Medical Co., Ltd. Class H (HK:2675), Elevance Health (ELV) and 4DMedical Ltd (AU:4DX) - The Globe and Mail
Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 13.86% Potential Upside for Investors - DirectorsTalk Interviews
Elevance Health Inc Stock (ELV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):